Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Dr. Reddys Labs Bags Health Canada Nod for Ozempic Generic, OneSource to Scale Supply

Dr Reddy's Labs receives positive EMA Committee opinion for proposed biosimilar of Prolia, Xgeva

Written By Ruchika Sharma23 Sept 2025 11:24 AM IST

Hyderabad: Dr Reddy's Laboratories Ltd., has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use...

Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector Version

Sanofi Tolebrutinib faces USFDA review delay; new target action date set for December 28

Written By Ruchika Sharma22 Sept 2025 5:09 PM IST

Paris: Sanofi has announced that the US Food and Drug Administration (FDA) has extended by three months the target action date of its review of...

AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus

AstraZeneca-Amgen Tezspire recommended for approval in EU for chronic rhinosinusitis with nasal polyps

Written By Ruchika Sharma22 Sept 2025 2:00 PM IST

Cambridge: AstraZeneca and Amgen's Tezspire (tezepelumab) has been recommended for approval in the European Union (EU) for the treatment of adult...

Aarti Pharmalabs Gets Single Observation in USFDA Inspection at Tarapur Unit

Jubilant Pharma arm completes USFDA inspection with zero observations

Written By Ruchika Sharma22 Sept 2025 11:01 AM IST

Noida: Jubilant Pharmova Limited has announced the completion of the United States Food and Drug Administration (USFDA) Post-marketing Adverse Drug...

Inspection Finds Bilaspur Ayurvedic Hospital Functioning Smoothly

Zydus gets USFDA EIR for Ahmedabad oncology injectable manufacturing facility

Written By Ruchika Sharma22 Sept 2025 10:51 AM IST

Ahmedabad: Zydus has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) for a GMP follow-up...

Merck receives positive EU CHMP opinion for Enflonsia for RSV in infants

Written By Ruchika Sharma21 Sept 2025 4:15 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada,,has announced that the Committee for Medicinal Products for Human Use (CHMP) of...

Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss Entry

Roche subcutaneous formulation of Lunsumio recommended by CHMP for EU nod for follicular lymphoma

Written By Ruchika Sharma21 Sept 2025 2:45 PM IST

Basel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of...

Bayer new drug application for gadoquatrane accepted for review in China

Written By Ruchika Sharma21 Sept 2025 2:00 PM IST

Berlin: Bayer today announced that the Center of Drug Evaluation of China's National Medical Products Administration has accepted the new drug...

Johnson and Johnson Gets USFDA Nod for Oral Psoriasis Drug Icotyde

JnJ gets positive CHMP opinion of nipocalimab for antibody-positive patients living with generalised myasthenia gravis

Written By Ruchika Sharma21 Sept 2025 11:30 AM IST

Beerse: Johnson & Johnson has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...

Lupin Launches Bioequivalent of Xigduo XR in US Across Multiple Strengths

Lupin gets 4 USFDA observations for Pune Biotech facility

Written By Ruchika Sharma20 Sept 2025 2:45 PM IST

Mumbai: Lupin has announced that the company has received four observations from the U.S. Food and Drug Administration (USFDA) after an inspection at...

No False Advertising Found: US Court Rejects Bayer Plea to Block Erleada Ads

Bayer Elinzanetant recommended for nod in EU for moderate to severe vasomotor symptoms

Written By Ruchika Sharma20 Sept 2025 2:04 PM IST

Berlin: Bayer has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...

Johnson and Johnson Gets CDSCO Panel Nod for Talqetamab in Relapsed Multiple Myeloma, Phase IV Trial Mandated

JnJ Tremfya gets USFDA approval for subcutaneous induction in adults with ulcerative colitis

Written By Ruchika Sharma20 Sept 2025 12:50 PM IST

Horsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved a subcutaneous (SC) induction regimen of...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok